Garenoxacin
- Catalog NO.:A25162
- CAS No. : 194804-75-6
- Molecular Formula:C23H20F2N2O4
- Molecular Weight: 426.42
1. Please click the to confirm the discount and stock quantity.
2. Click“Bulk Inquiry”to ask for quotations of other quantity.
3. The price does not include shipping and bank charges.
Product Details
CAS Number | 194804-75-6 | Appearance | |
Catalog Number | A25162 | MDL Number | MFCD08141853 |
Molecular Formula | C23H20F2N2O4 | Molecular Weight | 426.42 |
Boiling Point | 581.5°C at 760 mmHg | Melting Point | |
Flash Point | Density | ||
Synonyms | BMS-284756;1-cyclopropyl-8-(difluoromethoxy)-7-((R)-1-methylisoindolin-5-yl)-4-oxo-1,4-dihydroquinoline-3-carboxylic acid | ||
Storage Condition | Store in a tightly closed container,in a cool and dry place |
Safety
GHS Pictogram | |||
Signal Word | Warning | UN Number | |
Hazard Statements | H302-H315-H319-H335 | Class | |
Precautionary Statements | P261-P305+P351+P338 | Packing Group |
Description
Garenoxacin is a novel oral des-fluoro(6) quinolone with potent antimicrobial activity against common respiratory pathogens, including resistant strains. It has favourable pharmacokinetic profiles for maximum plasma concentration (Cmax) and area under the plasma concentration-time curve (AUC), with good penetration into sputum and otorhinolaryngological tissues. In clinical studies, the efficacy of Garenoxacin ranged from 92% to 96% in patients with bacterial pneumonia, mycoplasma pneumonia, chlamydial pneumonia and acute bronchitis. Garenoxacin is very effective in treating patients with upper and lower respiratory tract infections. |